Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |